DPHARMA
Second Interim Dividend (with Dividend Re-Investment Plan)
DUOPHARMA BIOTECH BERHAD |
Entitlement subject | Second Interim Dividend (with Dividend Re-Investment Plan) |
Entitlement description | Second interim dividend of RM0.018 per ordinary share. |
Ex-Date | 14 Apr 2022 |
Entitlement date | 15 Apr 2022 |
Entitlement time | 5:00 PM |
Financial Year End | 31 Dec 2021 |
Share transfer book & register of members will be | to closed from (both dates inclusive) for the purpose of determining the entitlement |
Payment Date | 13 May 2022 |
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers | 15 Apr 2022 |
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit | |
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange. | |
Number of new shares/securities issued (units) (If applicable) |
|
Entitlement indicator | Currency |
Entitlement in Currency | Malaysian Ringgit (MYR) 0.0180 |
Options Available to Shareholders | Cash or "Cash and Securities" |
Cash | |
Cash^ Entitlement | |
1 | |
Tax Indicator | Tax Exempt / Non-taxable |
Currency | Malaysian Ringgit (MYR) |
Amount | 0.0180 |
or "Cash and Securities" | |
Cash Entitlement | |
1 | |
Tax Indicator | Tax Exempt / Non-taxable |
Currency | Malaysian Ringgit (MYR) |
Amount | 0.0180 |
Re-invest Cash Entitlement into Securities | |
Entitlement | Malaysian Ringgit (MYR) 0.0180 |
Company Name |
DUOPHARMA BIOTECH BERHAD |
Issue Price per Unit | Malaysian Ringgit (MYR) 1.2900 |
Deadline To Respond | 05 May 2022 05:00 PM |
Securities Crediting Date | 13 May 2022 |
Available/Listing Date | 17 May 2022 |
Fractional Entitlement |
Cash in Lieu of Fraction
Malaysian Ringgit (MYR) 1.2900 per unit |
Note: You will receive Cash^ if you do not Re-invest. |
Registrar or Service Provider name, address, telephone no |
TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHD Unit 32-01, Level 32, Tower A, Vertical Business Suite, Avenue 3, Bangsar South, No. 8, Jalan Kerinchi 59200 Kuala Lumpur Wilayah Persekutuan Malaysia Tel:0327839299 Fax:0327839222 |
Remarks : |
The Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company") ("Board") has declared a second interim dividend of 1.8 sen per ordinary share in Duopharma Biotech ("Duopharma Biotech Shares") in respect of the financial year ended 31 December 2021. The Board has also determined the dividend reinvestment plan ("DRP") would apply to the second interim dividend. Following the above, on behalf of the Board, Mercury Securities Sdn Bhd had on 24 March 2022 announced that the issue price of the new Duopharma Biotech Shares to be issued pursuant to the DRP has been fixed at RM1.29 per Duopharma Biotech Share. This announcement is dated 24 March 2022. |
Announcement Info
Company Name | DUOPHARMA BIOTECH BERHAD |
Stock Name | DPHARMA |
Date Announced | 24 Mar 2022 |
Category | Entitlement(Notice of Book Closure) |
Reference Number | ENT-24032022-00005 |
Corporate Action ID | MY220324DRIP0001 |